Financials

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,950 $ 1,079
Short-term investments 7,857 12,893
Prepaid expenses and other current assets 78 84
Total Current Assets 9,885 14,056
Operating lease right-of-use asset 27 53
TOTAL ASSETS 9,912 14,109
Current liabilities    
Accounts payable 3,213 4,328
Accrued expenses 963 1,195
Current operating lease liability 30 58
Warrant liability 394 1,052
Total Current Liabilities 4,600 6,633
Total Liabilities 4,600 6,633
Stockholders’ Equity    
Convertible Preferred stock,  par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 1 1
Common stock,  par value $0.001, 250,000,000 shares authorized, 1,380,633 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 1 1
Additional paid in capital 689,641 689,539
Accumulated deficit (684,331) (682,065)
Total Stockholders’ Equity 5,312 7,476
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 9,912 $ 14,109

Source

v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 777 1,650
Selling, general and administrative  (including $102 and $718 from stock compensation granted to officers, directors and employees during the three months ended March 31, 2024 and 2023, respectively) 2,314 2,015
Loss from Operations 3,091 3,665
Other (Income) Expense    
Interest income (142) (164)
Interest expense 212
Change in fair value of warrant liability (658) (2,924)
Gain on extinguishment of debt (533)
Unrealized loss (gain) on marketable securities 2 (29)
Other (27)
Total Other (Income) Expense (825) (3,438)
Net Loss $ (2,266) $ (227)
Net Loss Per Share - Basic $ (1.64) $ (0.21)
Net Loss Per Share - Diluted $ (1.64) $ (0.21)
Weighted average common shares outstanding - basic 1,380,633 1,082,871
Weighted average common shares outstanding - diluted 1,380,633 1,082,871

Source

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (2,266) $ (227)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock based compensation - services 176  
Stock based compensation - officers, employees and board of directors 102 646  
Change in fair value of warrant liability (658) (2,924)  
Gain on extinguishment of share settled debt (533)  
Change in operating lease right-of-use assets 26 25  
Unrealized loss (gain) on marketable securities 2 (29)  
Changes in operating assets and liabilities:      
Decrease in prepaid expenses 6 16  
(Decrease) in accounts payable and accrued expenses (1,347) (29)  
(Decrease) in operating lease liability (28) (27)  
Net Cash Used in Operating Activities (4,163) (2,906)  
CASH FLOWS FROM INVESTING ACTIVITIES      
Sale (purchase) of investments 5,034 (6,989)  
Net Cash Provided by (Used in) Investing Activities 5,034 (6,989)  
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from issuance of common stock and prefunded warrants 6,268  
Net Cash Provided by Financing Activities 6,268  
Net Increase (Decrease) in Cash 871 (3,627)  
Cash at Beginning of Period 1,079 5,672 $ 5,672
Cash at End of Period 1,950 2,045 $ 1,079
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:      
Interest  
Income taxes  
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES      
Initial recognition of fair value of warrant liability 5,831  
Fair value of common stock issued to a vendor to settle accounts payable $ 287  

Source